FOXO1 and breast carcinoma: MiR-30 family (Ouzounova et al., 2013) has been reported to negatively regulate the AVEN expression in the breast cancer cell line, while Foxo1 (Cai et al., 2017) has a positive regulatory effect on AVEN expression in regulatory T cells.